| Net sales | 20.23a | 18.08a |
| Other operating income | 3.4a | 3.31a |
| Revenue | 23.63a | 21.4a |
| Change in inventories | 0.11a | -0.28a |
| Change in value in biological assets | 1.84a | 2.2a |
| Raw materials and consumables | -5.08a | -4.35a |
| Personnel costs | -2.78a | -2.66a |
| Other operating expenses | -10.42a | -9.56a |
| Result from participations in associated companies and joint ventures | -0.15a | 0.05a |
| EBITDA | 7.14a | 6.81a |
| Depreciation and impairment | -2.12a | -1.95a |
| Operating profit | 5.03a | 4.86a |
| Financial income | 0.08a | 0.09a |
| Financial expenses | -0.59a | -0.5a |
| Profit before tax | 4.52a | 4.44a |
| Income taxes | -0.88a | -0.82a |
| Profit for the year | 3.64a | 3.63a |
| Profit for the year attributable to | — | — |
| Owners of the parent | 3.64a | 3.68a |
| Non-controlling interests | -0.05a | 0a |